Patent · US Active

Adjuvant compositions

US9662385B2 · kind B2 · utility

12Cited by
11References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 29, 2013
Grant dateMay 30, 2017
Priority date
Expiry dateOct 21, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to adjuvant formulations comprising various combinations of triterpenoids, sterols, immunomodulators, polymers, and Th2 stimulators; methods for making the adjuvant compositions; and the use of the adjuvant formulations in immunogenic and vaccine compositions with different antigens. This invention further relates to the use of the formulations in the treatment of animals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.